Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Brazil in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 124
ISBN Number not applicable
Product Code GMD02531

Price

£1,650.00
approximately: $2,498 | €1,842

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report is an essential source for in-depth information and data relating to the Brazil In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Brazil

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Brazil.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Brazil.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 In Vitro Diagnostics Devices
    • 3.2 Clinical Chemistry Test Reagents
      • 3.2.1 Laboratory Reagents
      • 3.2.2 Clinical Chemistry Calibrators and Controls
      • 3.2.3 Clinical Chemistry Rapid Tests
    • 3.3 Immunochemistry Test Reagents
      • 3.3.1 Disease Specific Markers
      • 3.3.2 Disease Specific Test Reagents
      • 3.3.3 Drug Related Testing Reagents
      • 3.3.4 Hormone Related Testing Reagents
      • 3.3.5 Immunochemistry Calibrators and Controls
      • 3.3.6 Immunochemistry Rapid Tests
    • 3.4 Blood Test Reagents
      • 3.4.1 Hematology Test Reagents
      • 3.4.2 Hemostasis Test Reagents
      • 3.4.3 Tissue Typing Reagents
      • 3.4.4 Monoclonal Antibodies
      • 3.4.5 Cytokines and Immunomodulators
      • 3.4.6 Histology and Cytology Reagents
    • 3.5 Microbiology Test Reagents
      • 3.5.1 Bacteriology Test Reagents
      • 3.5.2 Microbiology Calibrators and Controls
      • 3.5.3 Microbiology Rapid Tests
    • 3.6 Infectious Immunology Test Reagents
      • 3.6.1 Bacteriology
      • 3.6.2 Virology
      • 3.6.3 Parasitology
      • 3.6.4 Infectious Immunology Calibrators and Controls
      • 3.6.5 Infectious Immunology Rapid Tests
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Device Registration Protocol
      • 5.1.1 Registration Documentation
      • 5.1.2 Registration Procedure
      • 5.1.3 Medical Device Registration Fee
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Brazil
    • 8.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, Brazil Company Share (2006-2007)
  • 9 Blood Test Reagents In Brazil
    • 9.1 Blood Test Reagents Overall Revenue (2000-2015)
      • 9.1.1 Haematology Test Reagents Revenue (2000-2015)
      • 9.1.2 Hemostasis Test Reagents Revenue (2000-2015)
    • 9.2 Blood Test Reagents Distribution Share (2007-2008)
    • 9.3 Blood Test Reagents, Brazil, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In Brazil
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2007-2008)
    • 10.3 Clinical Chemistry Test Reagents, Brazil, Company Share (2006-2007)
  • 11 Genetic Test Reagents In Brazil
    • 11.1 Genetic Test Reagents Overall Revenue (2000-2015)
    • 11.2 Genetic Test Reagents Distribution Share (2007-2008)
    • 11.3 Genetic Test Reagents, Brazil, Company Share (2006-2007)
  • 12 Immunochemistry Test Reagents In Brazil
    • 12.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
      • 12.1.1 Disease Specific Markers Revenue (2000-2015)
      • 12.1.2 Disease Specific Test Reagents
      • 12.1.3 Drug Related Testing Reagents Revenue (2000-2015)
      • 12.1.4 Hormone Related Testing Reagents Revenue (2000-2015)
    • 12.2 Immunochemistry Test Reagents Distribution Share (2007-2008)
    • 12.3 Immunochemistry Test Reagents, Brazil, Company Share (2006-2007)
  • 13 Infectious Immunology Test Reagents In Brazil
    • 13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
      • 13.1.1 Virology Revenue (2000-2015)
    • 13.2 Infectious Immunology Test Reagents Distribution Share (2007-2008)
    • 13.3 Infectious Immunology Test Reagents, Brazil, Company Share (2006-2007)
  • 14 Instruments In Brazil
    • 14.1 Instruments Overall Revenue (2000-2015)
    • 14.2 Instruments Distribution Share (2007-2008)
  • 15 Microbiology Test Reagents In Brazil
    • 15.1 Microbiology Test Reagents Overall Revenue (2000-2015)
      • 15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
    • 15.2 Microbiology Test Reagents Distribution Share (2007-2008)
    • 15.3 Microbiology Test Reagents, Brazil, Company Share (2006-2007)
  • 16 Self Testing In Brazil
    • 16.1 Self Testing Overall Revenue (2000-2015)
    • 16.2 Self Testing Distribution Share (2007-2008)
    • 16.3 Self Testing, Brazil, Company Share (2006-2007)
  • 17 Overview of Key Companies in Brazil In Vitro Diagnostics Market
    • 17.1 F. Hoffmann-La Roche Ltd. Company Profile
      • 17.1.1 Company Overview
      • 17.1.2 Value Chain Analysis
    • 17.2 Abbott Laboratories Company Profile
      • 17.2.1 Company Overview
      • 17.2.2 Value Chain Analysis
      • 17.2.3 Abbott Laboratories Pipeline Products
    • 17.3 Ortho-Clinical Diagnostics Inc. Company Profile
      • 17.3.1 Company Overview
      • 17.3.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
    • 17.4 Beckman Coulter, Inc. Company Profile
      • 17.4.1 Company Overview
      • 17.4.2 Value Chain Analysis
      • 17.4.3 Beckman Coulter, Inc. Pipeline Products
    • 17.5 bioMerieux S.A. Company Profile
      • 17.5.1 Company Overview
      • 17.5.2 Value Chain Analysis
    • 17.6 Dade Behring Holdings, Inc. Company Profile
      • 17.6.1 Company Overview
    • 17.7 Digene Corporation Company Profile
      • 17.7.1 Company Overview
    • 17.8 Siemens Healthcare Company Profile
      • 17.8.1 Company Overview
      • 17.8.2 Value Chain Analysis
    • 17.9 Gen-Probe Incorporated Company Profile
      • 17.9.1 Company Overview
      • 17.9.2 Value Chain Analysis
      • 17.9.3 Gen-Probe Incorporated Pipeline Products
    • 17.10 Becton, Dickinson and Company Company Profile
      • 17.10.1 Company Overview
      • 17.10.2 Value Chain Analysis
  • 18 Financial Deals Landscape
    • 18.1 Acquisition
      • 18.1.1 FIR Capital Partners Sells Stake In Prodimol Biotecnologia To Orgenics
  • 19 Appendix
    • 19.1 Global Markets Direct Research Methodology
    • 19.2 Coverage
    • 19.3 Secondary Research
    • 19.4 Primary Research
    • 19.5 Models
    • 19.6 Forecasts
    • 19.7 Expert Panel Validation
    • 19.8 Currency Conversion
    • 19.9 Contact Us
    • 19.10 Disclaimer
  • 1 List of Tables
    • Table 1: Medical Device Registration Fee in Brazil, 2002
    • Table 2: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
    • Table 3: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015
    • Table 4: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 5: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 6: In Vitro Diagnostics, Brazil Company Share by Revenue ($ mn), 2006-2007
    • Table 7: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 8: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 9: Haematology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 10: Haematology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 11: Hemostasis Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 12: Hemostasis Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 13: Blood Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 14: Blood Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 15: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 16: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 17: Clinical Chemistry Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 18: Clinical Chemistry Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 19: Genetic Test Reagents, Brazil, Revenue ($ mn), Historic, 2000-2008
    • Table 20: Genetic Test Reagents, Brazil, Revenue ($ mn), Forecast, 2008-2015
    • Table 21: Genetic Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 22: Genetic Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 24: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 25: Disease Specific Markers, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 26: Disease Specific Markers, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 27: Disease Specific Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 28: Disease Specific Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 29: Drug Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 30: Drug Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 31: Hormone Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 32: Hormone Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 33: Immunochemistry Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 34: Immunochemistry Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 36: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 37: Virology, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 38: Virology, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 39: Infectious Immunology Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 40: Infectious Immunology Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 41: Instruments, Brazil, Revenue ($ mn), Historic, 2000-2008
    • Table 42: Instruments, Brazil, Revenue ($ mn), Forecast, 2008-2015
    • Table 43: Instruments, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 44: Microbiology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 45: Microbiology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 46: Bacteriology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 47: Bacteriology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 48: Microbiology Test Reagents, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 49: Microbiology Test Reagents, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 50: Self Testing, Brazil, Revenue ($ mn), Historic, 2000-2008
    • Table 51: Self Testing, Brazil, Revenue ($ mn), Forecast, 2008-2015
    • Table 52: Self Testing, Brazil, Distribution Share by Revenue ($mn), 2007-2008
    • Table 53: Self Testing, Brazil, Company Share by Revenue ($ mn), 2006-2007
    • Table 54: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 55: Abbott Laboratories Pipeline Products By Development Stage
    • Table 56: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 57: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 58: Abbott Laboratories Pipeline Products By News Summary
    • Table 59: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
    • Table 60: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
    • Table 61: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
    • Table 62: Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • Table 63: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 64: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 65: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 66: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 67: Gen-Probe Incorporated Pipeline Products by Equipment Type
    • Table 68: Gen-Probe Incorporated Pipeline Products By Development Stage
    • Table 69: Gen-Probe Incorporated Pipeline Products By Therapy Area
    • Table 70: Gen-Probe Incorporated Pipeline Products By Clinical Trials
    • Table 71: Gen-Probe Incorporated Pipeline Products By News Summary
    • Table 72: FIR Capital Partners Sells Stake In Prodimol Biotecnologia To Orgenics
    • Table 73: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Health Expenditure by Source in Brazil
    • Figure 2: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
    • Figure 3: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015
    • Figure 4: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 5: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 6: In Vitro Diagnostics, Brazil Company Share (%), 2007
    • Figure 7: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 8: Blood Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 9: Haematology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 10: Haematology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 11: Hemostasis Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 12: Hemostasis Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 13: Blood Test Reagents, Brazil, Company Share (%), 2007
    • Figure 14: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 15: Clinical Chemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 16: Clinical Chemistry Test Reagents, Brazil, Company Share (%), 2007
    • Figure 17: Genetic Test Reagents, Brazil, Revenue ($ mn), Historic, 2000-2008
    • Figure 18: Genetic Test Reagents, Brazil, Revenue ($ mn), Forecast, 2008-2015
    • Figure 19: Genetic Test Reagents, Brazil, Company Share (%), 2007
    • Figure 20: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 21: Immunochemistry Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 22: Disease Specific Markers, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 23: Disease Specific Markers, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 24: Disease Specific Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 25: Disease Specific Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 26: Drug Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 27: Drug Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 28: Hormone Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 29: Hormone Related Testing Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 30: Immunochemistry Test Reagents, Brazil, Company Share (%), 2007
    • Figure 31: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 32: Infectious Immunology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 33: Virology, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 34: Virology, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 35: Infectious Immunology Test Reagents, Brazil, Company Share (%), 2007
    • Figure 36: Instruments, Brazil, Revenue ($ mn), Historic, 2000-2008
    • Figure 37: Instruments, Brazil, Revenue ($ mn), Forecast, 2008-2015
    • Figure 38: Microbiology Test Reagents, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 39: Microbiology Test Reagents, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 40: Bacteriology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 41: Bacteriology Test Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 42: Microbiology Test Reagents, Brazil, Company Share (%), 2007
    • Figure 43: Self Testing, Brazil, Revenue ($ mn), Historic, 2000-2008
    • Figure 44: Self Testing, Brazil, Revenue ($ mn), Forecast, 2008-2015
    • Figure 45: Self Testing, Brazil, Company Share (%), 2007
    • Figure 46: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 47: Abbott Laboratories Value Chain Analysis
    • Figure 48: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 49: Biomerieux Sa Value Chain Analysis
    • Figure 50: Siemens Medical Solutions Value Chain Analysis
    • Figure 51: Gen-Probe Incorporated Value Chain Analysis
    • Figure 52: Becton, Dickinson and Company Value Chain Analysis
    • Figure 53: Global Markets Direct Methodology